Evidence map›Paper›PMID 33947738›Full record

ArticleBMJ open2021

Effects of non-pharmacological and non-surgical interventions on health outcomes in systemic sclerosis: protocol for a living systematic review.

Marie-Nicole Discepola, Andrea Carboni-Jiménez, Linda Kwakkenbos, Richard S Henry, Jill Boruff, Ankur Krishnan, Carina Boström, S Nicole Culos-Reed, Marie Hudson, David M Leader and 9 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 5 countries.

Marie-Nicole DiscepolaLady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada.
Andrea Carboni-JiménezLady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada.
Linda KwakkenbosDepartment of Clinical Psychology, Behavioural Science Institute, Radboud Universiteit, Nijmegen, The Netherlands.
Richard S HenryLady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada.
Jill BoruffSchulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montreal, Quebec, Canada.
Ankur KrishnanLady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada.
Carina BoströmDepartment of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Stockholm, Sweden.
S Nicole Culos-ReedFaculty of Kinesiology, University of Calgary, Calgary, Alberta, Canada.
Marie HudsonDepartment of Medicine, McGill University Faculty of Medicine, Montreal, Quebec, Canada.
David M LeaderTufts University School of Dental Medicine, Boston, Massachusetts, USA.
Malin MattssonDepartment of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Stockholm, Sweden.
Luc MouthonService de Médecine Interne, Centre de Référence Maladies Auto-immunes et Systémiques Rares d'Ile de France, Hopital Cochin Assistance Publique - Hôpitaux de Paris (APHP), Paris, France.
Robyn WojeckSchool of Nursing, Duke University, Durham, North Carolina, USA.
Elizabeth Yakes JimenezDepartments of Pediatrics and Internal Medicine and College of Population Health, University of New Mexico, Albuquerque, California, USA.
Maureen SauveScleroderma Societies of Canada and Ontario, Hamilton, Ontario, Canada.
Joep WellingFESCA Patient Research Partner, Utrecht, The Netherlands.
Geneviève GuillotSclérodermie Québec, Montreal, Quebec, Canada.
Andrea BenedettiDepartment of Medicine, McGill University Faculty of Medicine, Montreal, Quebec, Canada.
Brett D ThombsLady Davis Institute of the Jewish General Hospital, Montreal, Quebec, Canada brett.thombs@mcgill.ca.ORCID 0000-0002-5644-8432
Jewish General Hospital · CAKarolinska Institutet · SEMcGill University · CADuke University · USMcGill University Health Centre · CAMultiple Sclerosis Society of Canada · CARadboud University Nijmegen · NLTufts University · USUniversité Paris Cité · FRUniversity of Calgary · CAUniversity of New Mexico · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionSystemic sclerosis (SSc; scleroderma) is a rare, chronic, autoimmune disease with a high level of burden, a significant impact on the ability to carry out daily activities, and a considerable negative impact on health-related quality of life. Non-pharmacological interventions could be provided to potentially improve mental and physical health outcomes. However, the effectiveness of non-pharmacological interventions on health and well-being among individuals with SSc has not been well established. The proposed living systematic review aims to identify and evaluate randomised controlled trial (RCT) evidence on the effectiveness of non-pharmacological and non-surgical interventions on mental and physical health outcomes and on the delivery of such services in SSc. METHODS AND ANALYSIS: Eligible studies will be RCTs that examine non-pharmacological and non-surgical interventions aimed at improving health outcomes among individuals with SSc or the delivery of services intended to improve healthcare or support of people with SSc (eg, support groups). All RCTs included in a previous systematic review that sought studies published between 1990 and March 2014 will be evaluated for inclusion. Additional trials will be sought from January 2014 onwards using a similar, augmented search strategy developed by a health sciences librarian. We will search the MEDLINE, Embase, CINAHL, PsycINFO, Cochrane Library and Web of Science databases and will not restrict by language. Two independent reviewers will determine the eligibility of identified RCTs and will extract data using a prespecified standardised form in DistillerSR. Meta-analyses will be considered if ≥2 eligible RCTs report similar non-pharmacological interventions and comparable health outcomes. We will conduct a qualitative synthesis for interventions that cannot be synthesised via meta-analysis. ETHICS AND DISSEMINATION: We will post initial and ongoing results via a website, publish results periodically via peer-reviewed journal publication, and present results at patient-oriented events. PROSPERO REGISTRATION NUMBER: CRD42020219914.

Indexed as

Quality of LifeScleroderma, SystemicChronic DiseaseHumansOutcome Assessment, Health CareSystematic Reviews as Topichealth services administration & managementimmunologyrheumatology

Identifiers

PMID33947738
PMCPMC8098987
OpenAlexW3158061846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.